graft-versus-host disease

[iScience] RNA-sequencing analysis of zymosan-treated MSCs showed that calcineurin-NFAT inhibition affects extracellular matrix genes, but not cytokine expression that is under the control of the NF-κB pathway.

[Leukemia] The authors reported on 382 COVID-19 patients having undergone allogeneic or autologous hematopoietic cell transplantation reported to the European Society for Blood and Marrow Transplantation (EBMT) or to the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH).

[Bone Marrow Transplantation] Researchers performed a retrospective, registry-based analysis to elucidate the prognostic value of runt-related transcription factor 1 (RUNX1) mutation after allogeneic stem cell transplantation for AML patients.

[Bone Marrow Transplantation] Investigators reported 236 adult patients who received haploidentical HSC transplantation with post-transplant cyclophosphamide.

[Clinical infectious Diseases] Scientists examined the abundance and butyrogenic capacity of butyrate producing bacteria in 28 healthy donors and 201 patients after allogeneic stem cell transplantation.

[Bone Marrow Transplantation] To improve the efficiency of graft-versus-host disease (GvHD) prophylaxis in matched unrelated donor peripheral blood stem cell transplantation, 51 patients with hematological malignancies received a novel regimen for GvHD prophylaxis composed of low dose antithymocyte globulin.